Valuation (53%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 22.43 | N/A |
| PEG Ratio (TTM) | -2.94 | N/A |
| P/S Ratio (TTM) | 3.61 | N/A |
| P/B Ratio (TTM) | 1.54 | N/A |
| P/FCF Ratio (TTM) | 12.89 | N/A |
| Price to 5YR AVG Earnings Ratio | 18.96 | N/A |
| Price to 5YR AVG FCF Ratio | 15.07 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.83% | N/A |
| ROE (TTM) | 7.17% | N/A |
| Net Profit Margin (TTM) | 16.10% | N/A |
| ROIC 5YR AVG | 24.97% | N/A |
Growth (78%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 4.11% | 34.31% | 13.22% |
| Revenue | 6.56% | 22.14% | 9.63% |
| Net Income | 4.23% | 59.82% | 28.29% |
| Cash Flow | 33.03% | -156.96% | 158.84% |
Health (44%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.21 | N/A |
| Quick Ratio (TTM) | 1.21 | N/A |
| D/E Ratio (TTM) | 0.12 | N/A |
| Interest Coverage (TTM) | 0.58 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 0.38 | N/A |
| LTL to 5YR AVG FCF | 2.93 | N/A |
| Shares Outstanding Growth 5YR AVG | 9.44% | N/A |